跳至主要内容
临床试验/NCT02960464
NCT02960464Unknown不适用

Transcranial Direct Current Stimulation for Treatment of Depression in Parkinson's Disease, a Randomized Placebo-controlled Clinical Trial

Hospital Santa Marcelina1 个研究点 分布在 1 个国家目标入组 50 人开始时间: 2016年10月最近更新:
适应症

试验速览

阶段
不适用
入组人数
50
试验地点
1
主要终点
Hamilton Rating Scale for Depression

研究概览

简要总结

Investigation of possible benefits of transcranial direct current stimulation (tDCS) as a treatment of depression in patients with Parkinson's Disease, through a randomized placebo-controlled clinical trial.

详细描述

We aim to investigate the effects of transcranial direct current stimulation (tDCS) as treatment for depression in patients with Parkinson's Disease. We have designed a clinical trial in which volunteers that fulfill inclusion criteria will receive 15 sessions of tDCS during 1 week (3 sessions a day, with 30 minutes interval in between). Subjects will be randomly allocated into two groups, one that will receive the real intervention (active) and the other that will receive the placebo intervention (sham). The collaborator in charge of administering the session will not participate in the evaluations, keeping both subjects and evaluators blinded to the nature of the sessions. Subjects will be evaluated at baseline, and after the end of sessions, 1 week, 4 weeks and 8 weeks, the latter being the main outcome.

We aim to enroll 50 subjects, 25 for each arm. The sample size calculation took into consideration previous clinical trials using tDCS for depression in different settings.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double (Participant, Outcomes Assessor)

入排标准

年龄范围
35 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Idiopathic Parkinson's Disease
  • Geriatric Depression Scale - 15 higher that 5
  • Major Depression Disorder

排除标准

  • CNS disease other than Parkinson's Disease (i.e. epilepsy, stroke)
  • Mental disorder other than depression on anxiety disorder (i.e. bipolar disorder, schizophrenia)
  • Previous neurosurgical intervention (i.e. DBS)
  • Current use of antidepressant drug
  • High suicidality risk
  • Limited capacity of understanding written and spoken Portuguese

结局指标

主要结局

Hamilton Rating Scale for Depression

时间窗: 8 weeks

次要结局

  • Quantitative EEG(8 weeks)
  • Geriatric Depression Scale -15(8 weeks)
  • Parkinson's Disease Questionnaire - 39(8 weeks)
  • Mini-Mental State Examination(8 weeks)
  • Hamilton Anxiety Rating Scale(8 weeks)
  • Montgomery-Åsberg Depression Rating Scale(8 weeks)
  • Lille apathy rating scale(8 weeks)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Pedro Caldana Gordon

Principal Investigator

Hospital Santa Marcelina

研究点 (1)

Loading locations...

相似试验

tDCS for Treatment of Depression in Parkinson's... | 临床试验